Long-term follow-up data from a phase 2b trial of Moderna and MSD's mRNA-based vaccine against melanoma, intismeran autogene (mRNA-4157), show an impressive 49% reduction in the risk of disease ...
MSD has fleshed out the results of phase 3 trials of its cholesterol-lowering, oral PCSK9 inhibitor, enlicitide decanoate, showing its efficacy was comparable to that of injectable alternatives. The ...
The NEW 5977B High Efficiency Source (HES) GC/MSD builds on a tradition of providing the most trusted single-quadrupole GC/MS system. The ultra-efficient EI source maximizes the number of ions that ...
The DB-17 GC Column is a (50%-Phenyl)- methylpolysiloxane column of mid polarity. The DB-17 GC Column is excellent for confirmation analysis. The DB-17 GC Column is equivalent to USP Phase G3. Agilent ...
Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New School ...
Redis, the world's fastest data platform, is releasing Redis Feature Form, a managed feature store platform built to help enterprise ML teams bring features into production with more control, ...
Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International stock ...
Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...
Agilent Certified Pre-Owned Instruments deliver unmatched quality at an affordable price. Every instrument goes through a rigorous cleaning and refurbishment procedure at an Agilent Technologies ...
This webinar will introduce you to some considerations and solutions for integration of chromatogram and processing of data using Agilent OpenLAB Chemstation. Topics include useful knowledge for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results